We are live on ! Find out more
MGNX icon

MacroGenics
MGNX

125 hedge funds and large institutions have $759M invested in MacroGenics in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 49 increasing their positions, 36 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,075% more call options, than puts

Call options by funds: $734K | Put options by funds: $8K

45% more capital invested

Capital invested by funds: $523M → $759M (+$236M)

36% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 36

1% less funds holding

Funds holding: 126 → 125 (-1)

7% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 15

Holders
125
Holders Change
-1
Holders Change %
-0.79%
% of All Funds
3.33%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
49
Reduced
36
Closed
15
Calls
$734K
Puts
$8K
Net Calls
+$726K
Net Calls Change
+$1.01M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$32.4M
2
BB
BB Biotech
Switzerland
+$11.7M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.07M
4
BI
BVF Inc
California
+$4.51M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.37M

Top Sellers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
-$11.3M
2
DM
Deerfield Management
New York
-$9.71M
3
Millennium Management
Millennium Management
New York
-$8.45M
4
TM
Tiger Management
New York
-$5.91M
5
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$4.61M

MGNX Hedge Fund Activity: Q2 2016 in Review

125 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2016, worth a combined $759M — up 45% from $523M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of MGNX and 14 opened new positions — a net loss of 1 holder — while 36 trimmed existing stakes and 49 added.

The largest buyer was Fidelity Investments, adding an estimated $32.4M. The largest seller was Numeric Investors, cutting an estimated $11.3M.

  • 125 institutional investors held MacroGenics (MGNX) as of Q2 2016, down from 126 in Q1 2016.
  • Funds reported $759M of MacroGenics stock for Q2 2016, up 45% quarter-over-quarter.
  • 14 funds opened new MacroGenics positions in Q2 2016 and 15 closed out, a net change of -1 holder.
  • The largest MacroGenics buyer in Q2 2016 was Fidelity Investments, an estimated $32.4M added.
  • The largest MacroGenics seller in Q2 2016 was Numeric Investors, an estimated $11.3M sold.

Based on aggregated 13F filings for Q2 2016.